Novanta Inc (NOVT)

Currency in USD
127.87
-1.66(-1.28%)
Closed·
127.870.00(0.00%)
·
Earnings results expected in 9 days
NOVT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
125.47130.87
52 wk Range
98.27149.95
Key Statistics
Prev. Close
129.53
Open
129.53
Day's Range
125.47-130.87
52 wk Range
98.27-149.95
Volume
666.6K
Average Volume (3m)
391.76K
1-Year Change
4.8287%
Book Value / Share
36.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NOVT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
157.00
Upside
+22.78%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Novanta Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 157.00
(+22.78% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Buy144.00+12.61%150.00Upgrade30-03-2026
Baird
Hold150.00+17.31%138.00Maintain25-02-2026
Baird
Hold138.00+7.92%133.00Maintain05-11-2025
Baird
Hold133.00+4.01%139.00Maintain11-08-2025

Novanta Inc Earnings Call Summary for Q4/2025

  • Novanta Q4 2025 revenue hit $258.3M (up 9% YoY), beating forecasts by $3.13M; EPS of $0.91 matched estimates, rising 20% YoY
  • Adjusted EBITDA reached $61M (up 17% YoY), though operating cash flow declined sharply to $9M from $62M in Q4 2024
  • Stock rose 0.41% in premarket trading; company projects 2026 operating cash flow between $145M-$185M driven by regional manufacturing
  • CEO cited record revenue and strong bookings growth; strategic focus on regional manufacturing aims to enhance profitability and market leadership
  • Key risks include gross margin compression and elevated inventory levels; successful execution of strategic initiatives critical for projected benefits
Last Updated: 24-02-2026, 07:50 pm
Read Full Transcript

Earnings

Latest Release
24-02-2026
EPS / Forecast
0.91 / 0.91
Revenue / Forecast
258.3M / 255.17M
EPS Revisions
Last 90 days

NOVT Income Statement

Compare NOVT to Peers and Sector

Metrics to compare
NOVT
Peers
Sector
Relationship
P/E Ratio
84.6x50.7x12.8x
PEG Ratio
−4.990.730.01
Price/Book
3.5x2.1x2.4x
Price / LTM Sales
4.6x2.4x2.5x
Upside (Analyst Target)
22.8%14.1%23.1%
Fair Value Upside
Unlock0.9%2.9%Unlock

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
23.48M65.80%3.00B
Other Institutional Investors
17.35M34.20%2.22B
Public Companies & Retail Investors
0.000.00%0.00
Total
40.83M100.00%5.22B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.12.84%45,80,7295,85,738
The Vanguard Group, Inc.12.16%43,40,6985,55,045

FAQ

What Is the Novanta (NOVT) Share Price Today?

The Novanta share price today is 127.87.

What is the current Novanta (NOVT) share price and day range?

As of 02-05-2026, the Novanta share price is 127.87, with a previous close of 129.53. The share price has ranged from 125.47 to 130.87 today, while the 52-week range spans from 98.27 to 149.95.

What Is the Novanta Market Cap?

As of today, Novanta market cap is 4.55B.

What Is the Novanta (NOVT) Share Price Target?

The average 12-month share price target for Novanta is 157.00, with a high estimate of 170 and a low estimate of 144. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +22.78% Upside potential.

What Is Novanta's Earnings Per Share (TTM)?

The Novanta EPS (TTM) is 1.47.

When Is the Next Novanta Earnings Date?

Novanta will release its next earnings report on 11-05-2026.

From a Technical Analysis Perspective, Is NOVT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What Stock Exchange Does Novanta Trade On?

Novanta is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Novanta?

The stock symbol for Novanta is "NOVT."

How Many Times Has Novanta Stock Split?

Novanta has split 1 times.

How Many Employees Does Novanta Have?

Novanta has 3000 employees.

What Is the NOVT Premarket Price?

NOVT's last pre-market stock price is 129.72. The pre-market share volume is 30.00, and the stock has changed by 0.19, or 0.15%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.